Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medication
|
| gptkbp:activeDuring |
methylphenidate
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availableIn |
generic methylphenidate
|
| gptkbp:clinicalTrials |
safety profile established
efficacy in long-term use studied in adults studied in children |
| gptkbp:colors |
white
|
| gptkbp:contraindication |
glaucoma
heart problems history of drug abuse |
| gptkbp:dosageForm |
18 mg tablet
27 mg tablet 36 mg tablet 54 mg tablet |
| gptkbp:drugInterdiction |
true
|
| gptkbp:duration |
10 to 12 hours
|
| gptkbp:endOfLife |
3 to 4 hours
|
| gptkbp:events |
Schedule II controlled substance
|
| gptkbp:formFactor |
extended-release tablet
|
| gptkbp:healthcare |
avoid alcohol
do not crush or chew take in the morning report any mood changes |
| https://www.w3.org/2000/01/rdf-schema#label |
Concerta
|
| gptkbp:imprints |
CONCERTA
|
| gptkbp:inheritsFrom |
1 to 2 hours
|
| gptkbp:interactsWith |
gptkb:MAO_inhibitors
antidepressants blood pressure medications |
| gptkbp:is_monitored_by |
blood pressure
heart rate growth in children |
| gptkbp:lastProduced |
2000
|
| gptkbp:manufacturer |
gptkb:Janssen_Pharmaceuticals
|
| gptkbp:route |
oral
|
| gptkbp:shape |
round
|
| gptkbp:sideEffect |
headache
decreased appetite insomnia dry mouth nervousness stomach pain |
| gptkbp:storage |
room temperature
|
| gptkbp:symptoms |
depression
fatigue sleep disturbances seizures hallucinations rapid heartbeat agitation |
| gptkbp:usedFor |
treatment of ADHD
|